Myong Cheol Lim

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

Bradley J. Monk, Christine Parkinson, Myong Cheol Lim et al. · Journal of Clinical Oncology · 2022 · 384 citations · Full text

Medicine, Oncology, Pharmacology +16

Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial

Bradley J. Monk, Nicoletta Colombo, Amit M. Oza et al. · The Lancet Oncology · 2021 · 284 citations · Full text

Medicine, Gynecology, Oncology +11

Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer

Myong Cheol Lim, Suk‐Joon Chang, Boram Park et al. · JAMA Surgery · 2022 · 214 citations · Full text

Medicine, Oncology, Surgery +17

Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial

Jin Won Youn, Soo Young Hur, Jung Won Woo et al. · The Lancet Oncology · 2020 · 167 citations

Medicine, Immunology, Oncology +16

The Histology of Allergic Rhinitis and Its Comparison to Cellular Changes in Nasal Lavage

Myong Cheol Lim, R. M. R. Taylor, Robert M. Naclerio · American Journal of Respiratory and Critical Care Medicine · 1995 · 124 citations

Life Sciences, Immunology, Pathology +14